Literature DB >> 11242767

[Progressive hemifacial atrophy in the young patient: physiopathologic hypotheses, diagnosis and therapy].

B Ruhin1, S Bennaceur, F Verecke, S Louafi, B Seddiki, J Ferri.   

Abstract

Parry-Romberg syndrome is characterized by a limited progressive hemifacial atrophy. Since its first description in 1825, this syndrome has aroused interrogation and reflection about is pathophysiology, its variable clinical expression and its progression. The first part of this focuses on the different hypotheses advanced to date to explain this type of atrophy. We then recall the different steps for clinical diagnosis and treatment. Management of such an unpredictable disorder is particularly difficult. Because of the uncertain pathophysiology, medical therapy has not been very successful. Palliative reconstruction surgery remains the only possibility. We present three cases illustrating this review of progressive hemifacial atrophy.

Entities:  

Mesh:

Year:  2000        PMID: 11242767

Source DB:  PubMed          Journal:  Rev Stomatol Chir Maxillofac        ISSN: 0035-1768


  4 in total

1.  Chronologic presentation of a severe case of progressive hemifacial atrophy (parry-romberg syndrome) with the loss of an eye.

Authors:  Mesut Kaya; Ceyda Sel Yilmaz; Hanifi Kurtaran; Mehmet Gunduz
Journal:  Case Rep Otolaryngol       Date:  2014-11-18

Review 2.  Oral manifestations of Parry-Romberg syndrome: A review of literature.

Authors:  Nader A Al-Aizari; Saleh Nasser Azzeghaiby; Hashem Motahir Al-Shamiri; Shourouk Darwish; Bassel Tarakji
Journal:  Avicenna J Med       Date:  2015 Apr-Jun

3.  Lower limb onset Parry-Romberg syndrome: an unusual presentation of a rare disease.

Authors:  Rajendra Singh Jain; Sunil Kumar; Trilochan Srivastava
Journal:  Oxf Med Case Reports       Date:  2016-08-29

4.  A Unique Case of Progressive Hemi-facial Atrophy Successfully Treated with Methotrexate.

Authors:  Nichelle Arnold; Shahjahan Shareef; Lynn Sikorski
Journal:  Spartan Med Res J       Date:  2017-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.